Find link

language:

Find link is a tool written by Edward Betts.

searching for Tesaro 7 found (122 total)

alternate case: tesaro

PARP inhibitor (2,065 words) [view diff] exact match in snippet view article find links to article

medpagetoday.com. 19 December 2016. Zejula FDA Professional Drug Information. "Tesaro earns CHMP thumbs-up for Zejula as three-way PARP race heats up | FiercePharma"

Niraparib (1,265 words) [view diff] exact match in snippet view article find links to article

fast track designation by the US Food and Drug Administration (FDA), and Tesaro submitted a new drug application in 2016. It was approved on 27 March 2017

Checkpoint inhibitor (2,093 words) [view diff] exact match in snippet view article find links to article

Regeneron PD-1 2018 squamous cell carcinoma, basal cell carcinoma, non-small cell lung cancer Dostarlimab Jemperli Tesaro PD-1 2021 endometrial cancer

Institute for Clinical and Economic Review (1,643 words) [view diff] exact match in snippet view article find links to article

Retrieved 2021-03-31. "Cancer-fighting PARP drugs from AstraZeneca, Clovis and Tesaro largely overpriced, watchdog says". FiercePharma.com. Retrieved 25 June

Lymphocyte-activation gene 3 (6,646 words) [view diff] exact match in snippet view article find links to article

Gastroesophageal Junction Adenocarcinoma" at ClinicalTrials.gov "Tesaro's Immuno-Oncology Platform". Tesaro web site. "Technology Platforms". Immutep LAG-3. Archived

HAVCR2 (2,940 words) [view diff] exact match in snippet view article find links to article

(LY3321367, Eli Lilly and Company; MBG453, Novartis Pharmaceuticals; TSR-022, Tesaro, Inc.) in combination with anti-PD-1 or anti-PD-L1 therapies are ongoing

Pharmaceutical industry in China (12,115 words) [view diff] exact match in snippet view article find links to article

Retrieved 27 March 2017.{{cite web}}: CS1 maint: archived copy as title (link) "Tesaro and Jiangsu Hengrui Medicine Announce Rolapitant License Agreement for China